Contents
In line with its mission, the Editorial Board of MedTvoiLokony makes every effort to provide reliable medical content supported by the latest scientific knowledge. The additional flag “Checked Content” indicates that the article has been reviewed by or written directly by a physician. This two-step verification: a medical journalist and a doctor allows us to provide the highest quality content in line with current medical knowledge.
Our commitment in this area has been appreciated, among others, by by the Association of Journalists for Health, which awarded the Editorial Board of MedTvoiLokony with the honorary title of the Great Educator.
Symbicort Turbohaler is a medicine that contains budesonide and formoterol, which dilates the bronchi to facilitate the flow of air in the airways and is anti-inflammatory. It is mainly used in the treatment of diseases that manifest as bronchospasm. Simbicort Turbohaler is a drug that works very quickly and for a very long time. It is only available on prescription.
The active substance and effect of Symbicort Turbohaler
Symbicort Turbuhaler is manufactured by Astra Zeneca in the form of a powder inhaler. The drug is available in 4 doses: 80 µg budesonide, 4,5 µg formoterol; 320 µg budesonide, 9 µg formoterol; 160 µg budesonide, 4,5 µg formoterol; 160 µg budesonide, 4,5 µg formoterol. Symbicort Turbuhaler consists of two active substances: budesonide and formoterol.
Budesonide is an anti-inflammatory and anti-allergic substance. Its action is based on inhibiting inflammatory processes and reducing swelling and irritation. It partially reverses the changes that arise in the bronchial wall. Formoterol, the second base substance in Symbicort Turbohaler, works by stimulating the beta-2 type adrenergic receptors, which are found in the smooth muscle of the bronchi. Stimulating the receptors helps to relax the muscles and dilate the bronchial tubes, which improves or disappears breathlessness.
Using Symbicort Turbohaler
The preparation is intended for the systematic treatment of people suffering from asthma. However, please note that the Symbicort Turbohaler 80 µg + 4,5 µg dose is not recommended for the treatment of severe asthma. It is also used for symptomatic treatment of severe chronic obstructive pulmonary disease (COPD).
When should you not use Symbicort Turbohaler?
Symbicort Turbohaler should not be used by people who are allergic to any of the ingredients. Note that it also includes lactose. Children under 6 years of age must not take Symbicort Turbohaler. Children under 12 years of age should use a lower dose of the preparation (160 µg + 4,5 µg). Certain diseases (e.g., hyperthyroidism, cardiovascular disease, diabetes, tuberculosis) may contraindicate the use or dosage of the drug. Therefore, it is necessary to inform the doctor about any past and current illnesses.
After using the drug, slight muscle tremors, palpitations and increased heart rate, headaches, thrush in the mouth and throat may also occur. One of the more serious complications is anaphylactic shock. The preparation does not affect the ability to drive and use machines and does not affect the performance of other activities that require concentration.
Dosage of Symbicort Turbohaler
Symbicort Turbuhaler is for inhalation use only. The drug should be used only as directed by a doctor, not exceeding the recommended doses. Exceeding the dose may have a negative impact on health and life. Symbicort Turbohaler can be used for maintenance treatment, or for maintenance and reliever treatment.
320 µg + 9 µg / is only used for maintenance treatment. In maintenance and acute treatment, a dose of 160 µg + 4,5 µg / or 80 µg + 4,5 µg / is used. Any doubts or problems with the use of the preparation should be consulted immediately with a doctor.
Using Symbicort Turbohaler during pregnancy and breast-feeding
The use of Symbicort Turbohaler during pregnancy and breastfeeding is not recommended and requires consultation with your doctor.
| Name of the drug / preparation | Symbicort Turbuhaler |
| Wstęp | A drug containing budesonide and formoterol, which dilates the bronchi, facilitating the flow of air in the airways, and is anti-inflammatory |
| Manufacturer | Astra Zeneca |
| Form, dose, packaging | Powder inhaler available in 4 doses: 80 µg budesonide, 4,5 µg formoterol; 320 µg budesonide, 9 µg formoterol; 160 µg budesonide, 4,5 µg formoterol; 160 µg budesonide, 4,5 µg formoterol. |
| Availability category | Prescription available |
| The active substance | Budesonide and formoterol |
| Indication | Asthma and symptomatic treatment of severe chronic obstructive pulmonary disease |
| Dosage | It is determined by the doctor |
| Contraindications to use | Allergy to any ingredient of the drug and certain diseases. Children under 6 years of age should not use the drug |
| Warnings | x |
| Interactions | x |
| Side effects | Mild muscle tremors, palpitations and increased heart rate, headaches, oral and pharyngeal thrush, anaphylactic-type hypersensitivity |
| Other (if any) | x |
Before use, read the leaflet, which contains indications, contraindications, data on side effects and dosage as well as information on the use of the medicinal product, or consult your doctor or pharmacist, as each drug used improperly is a threat to your life or health.